Circulating and synovial antibody profiling of juvenile arthritis patients by nucleic acid programmable protein arrays
Arthritis Research & Therapy2012Vol. 14(2), pp. R77–R77
Citations Over TimeTop 10% of 2012 papers
Abstract
The NAPPAs provide a high-throughput quantitatively reproducible platform to screen for disease-specific autoantibodies at the proteome level on a microscope slide. The strong correlation between the circulating antibody levels and those of the inflamed joint represents a novel finding and provides confidence to use plasma for discovery of autoantibodies in JIA, thus circumventing the challenges associated with joint aspiration. We expect that autoantibody profiling of JIA patients on NAPPAs could yield antibody markers that can act as criteria to stratify patients, predict outcomes and understand disease etiology at the molecular level.
Related Papers
- → Autoantibodies, detection methods and panels for diagnosis of Sjögren's syndrome(2017)63 cited
- → The significance of preclinical anti-BP180 autoantibodies(2022)12 cited
- → Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65(2005)30 cited
- → Occurence of autoantibodies in healthy Omani individuals(2001)5 cited
- Analysis of autoantibodies in 83 patients with primary hepatic carcinnoma(2010)